99 related articles for article (PubMed ID: 38541981)
1. Does endovascular treatment of infra-inguinal arterial disease with drug-eluting stents offer better results than angioplasty with or without bare metal stents?
Antoniou GA; Georgakarakos EI; Antoniou SA; Georgiadis GS
Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):282-5. PubMed ID: 24729201
[TBL] [Abstract][Full Text] [Related]
2. Current Status of and Future Prospects for Drug-Eluting Stents and Scaffolds in Infrapopliteal Arteries.
Lim E; Varcoe RL
J Clin Med; 2024 Mar; 13(6):. PubMed ID: 38541981
[No Abstract] [Full Text] [Related]
3. Angioplasty versus stenting for infrapopliteal arterial lesions in chronic limb-threatening ischaemia.
Hsu CC; Kwan GN; Singh D; Rophael JA; Anthony C; van Driel ML
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD009195. PubMed ID: 30536919
[TBL] [Abstract][Full Text] [Related]
4. Stenting for peripheral artery disease of the lower extremities: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(18):1-88. PubMed ID: 23074395
[TBL] [Abstract][Full Text] [Related]
5. Sirolimus-eluting versus bare stents after suboptimal infrapopliteal angioplasty for critical limb ischemia: enduring 1-year angiographic and clinical benefit.
Siablis D; Karnabatidis D; Katsanos K; Kagadis GC; Kraniotis P; Diamantopoulos A; Tsolakis J
J Endovasc Ther; 2007 Apr; 14(2):241-50. PubMed ID: 17484536
[TBL] [Abstract][Full Text] [Related]
6. Balloon Angioplasty of Infrapopliteal Arteries: A Systematic Review and Proposed Algorithm for Optimal Endovascular Therapy.
Giannopoulos S; Varcoe RL; Lichtenberg M; Rundback J; Brodmann M; Zeller T; Schneider PA; Armstrong EJ
J Endovasc Ther; 2020 Aug; 27(4):547-564. PubMed ID: 32571125
[TBL] [Abstract][Full Text] [Related]
7. Drug-eluting stents for revascularization of infrapopliteal arteries: updated meta-analysis of randomized trials.
Fusaro M; Cassese S; Ndrepepa G; Tepe G; King L; Ott I; Nerad M; Schunkert H; Kastrati A
JACC Cardiovasc Interv; 2013 Dec; 6(12):1284-93. PubMed ID: 24355118
[TBL] [Abstract][Full Text] [Related]
8. Editor's Choice -- European Society for Vascular Surgery (ESVS) 2024 Clinical Practice Guidelines on the Management of Asymptomatic Lower Limb Peripheral Arterial Disease and Intermittent Claudication.
Nordanstig J; Behrendt CA; Baumgartner I; Belch J; Bäck M; Fitridge R; Hinchliffe R; Lejay A; Mills JL; Rother U; Sigvant B; Spanos K; Szeberin Z; van de Water W; ; Antoniou GA; Björck M; Gonçalves FB; Coscas R; Dias NV; Van Herzeele I; Lepidi S; Mees BME; Resch TA; Ricco JB; Trimarchi S; Twine CP; Tulamo R; Wanhainen A; ; Boyle JR; Brodmann M; Dardik A; Dick F; Goëffic Y; Holden A; Kakkos SK; Kolh P; McDermott MM
Eur J Vasc Endovasc Surg; 2024 Jan; 67(1):9-96. PubMed ID: 37949800
[No Abstract] [Full Text] [Related]
9. Drug-Eluting Resorbable Scaffold versus Angioplasty for Infrapopliteal Artery Disease.
Varcoe RL; DeRubertis BG; Kolluri R; Krishnan P; Metzger DC; Bonaca MP; Shishehbor MH; Holden AH; Bajakian DR; Garcia LA; Kum SWC; Rundback J; Armstrong E; Lee JK; Khatib Y; Weinberg I; Garcia-Garcia HM; Ruster K; Teraphongphom NT; Zheng Y; Wang J; Jones-McMeans JM; Parikh SA;
N Engl J Med; 2024 Jan; 390(1):9-19. PubMed ID: 37888915
[TBL] [Abstract][Full Text] [Related]
10. Primary results of the SAVAL randomized trial of a paclitaxel-eluting nitinol stent versus percutaneous transluminal angioplasty in infrapopliteal arteries.
van Overhagen H; Nakamura M; Geraghty PJ; Rao S; Arroyo M; Soga Y; Iida O; Armstrong E; Nakama T; Fujihara M; Ansari MM; Mathews SJ; Gouëffic Y; Jaff MR; Weinberg I; Pinto DS; Ohura N; Couch K; Mustapha JA
Vasc Med; 2023 Dec; 28(6):571-580. PubMed ID: 37844137
[TBL] [Abstract][Full Text] [Related]
11. A new resorbable magnesium scaffold for de novo coronary lesions (DREAMS 3): one-year results of the BIOMAG-I first-in-human study.
Haude M; Wlodarczak A; van der Schaaf RJ; Torzewski J; Ferdinande B; Escaned J; Iglesias JF; Bennett J; Toth GG; Joner M; Toelg R; Wiemer M; Olivecrano G; Vermeersch P; Garcia-Garcia HM; Waksman R
EuroIntervention; 2023 Aug; 19(5):e414-e422. PubMed ID: 37334655
[TBL] [Abstract][Full Text] [Related]
12. A vein bypass first versus a best endovascular treatment first revascularisation strategy for patients with chronic limb threatening ischaemia who required an infra-popliteal, with or without an additional more proximal infra-inguinal revascularisation procedure to restore limb perfusion (BASIL-2): an open-label, randomised, multicentre, phase 3 trial.
Bradbury AW; Moakes CA; Popplewell M; Meecham L; Bate GR; Kelly L; Chetter I; Diamantopoulos A; Ganeshan A; Hall J; Hobbs S; Houlind K; Jarrett H; Lockyer S; Malmstedt J; Patel JV; Patel S; Rashid ST; Saratzis A; Slinn G; Scott DJA; Zayed H; Deeks JJ;
Lancet; 2023 May; 401(10390):1798-1809. PubMed ID: 37116524
[TBL] [Abstract][Full Text] [Related]
13. Safety and performance of the third-generation drug-eluting resorbable coronary magnesium scaffold system in the treatment of subjects with de novo coronary artery lesions: 6-month results of the prospective, multicenter BIOMAG-I first-in-human study.
Haude M; Wlodarczak A; van der Schaaf RJ; Torzewski J; Ferdinande B; Escaned J; Iglesias JF; Bennett J; Toth G; Joner M; Toelg R; Wiemer M; Olivecrona G; Vermeersch P; Garcia-Garcia HM; Waksman R
EClinicalMedicine; 2023 May; 59():101940. PubMed ID: 37113674
[TBL] [Abstract][Full Text] [Related]
14. Bioresorbable vascular scaffolds versus conventional drug-eluting stents across time: a meta-analysis of randomised controlled trials.
Jackson-Smith E; Zioupos S; Banerjee P
Open Heart; 2022 Oct; 9(2):. PubMed ID: 36288820
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
